ERX1000 - Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Male and Female Subjects With Obesity
Clinical trial NCT04890873 · COMPLETED
Trial details
- NCT number
- NCT04890873
- Sponsor
- ERX Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2023-07-03
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.